Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
AJNR. American Journal of Neuroradiology|August 6, 2024
Gadolinium-Enhanced T2 FLAIR Is an Imaging Biomarker of Radiation Necrosis and Tumor Progression in Patients with Brain MetastasesChris Heyn, Jonathan Bishop, Alan R Moody, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 2024
Predictors of Tumor Dynamics Over a 6-Week Course of Concurrent Chemoradiotherapy for Glioblastoma and the Effect on SurvivalWee Loon Ong, James Stewart, Arjun Sahgal, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2020
Quantitating Interfraction Target Dynamics During Concurrent Chemoradiation for Glioblastoma: A Prospective Serial Imaging StudyJames Stewart, Arjun Sahgal, Young Lee, et al.
Practical Radiation Oncology|February 11, 2018
Pancreatic gross tumor volume contouring on computed tomography (CT) compared with magnetic resonance imaging (MRI): Results of an international contouring conferenceWilliam A Hall, Hanne D Heerkens, Eric S Paulson, et al.
JAMA Oncology|October 3, 2024
Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENsJonathan M Loree, David Chan, Jennifer Lim, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 30, 2021
Accuracy and precision of apparent diffusion coefficient measurements on a 1.5 T MR-Linac in central nervous system tumour patientsLiam S P Lawrence, Rachel W Chan, Hanbo Chen, et al.
Neurosurgery|August 15, 2021
The Initial Step Towards Establishing a Quantitative, Magnetic Resonance Imaging-Based Framework for Response Assessment of Spinal Metastases After Stereotactic Body Radiation TherapyPejman Jabehdar Maralani, Chia-Lin Tseng, Hamidreza Baharjoo, et al.
Lancet (London, England)|June 8, 2024
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 studySimron Singh, Daniel Halperin, Sten Myrehaug, et al.
Technology in Cancer Research & Treatment|June 28, 2022
Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort AnalysisJames Stewart, Arjun Sahgal, Aimee K M Chan, et al.
Frontiers in Oncology|December 15, 2022
High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first reportChia-Lin Tseng, Hanbo Chen, James Stewart, et al.
Pageof 14